Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 22 23 24 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Innovative Medicines Initiative–Bayer: cancer biomarker, 201504– collab Bayer HealthCare is coordinating partner of CANCER-ID project 2015-04-01
Innovative Medicines Initiative–EU (govt): grant, 201504– funding FP7 €6.3m for CANCER-ID project by IMI of €14.5m total budget 2015-04-01
Innovative Medicines Initiative–Univ Hamburg: cancer biomarker, 201504– collab UKE is coordinating partner of CANCER-ID project 2015-04-01
Merck (DE)–Medicines for Malaria Venture: antimalarial drug, 201504– acquisition rights to DDD107498 by Merck Serono 2015-04-01
Sanofi–Evotec: investment, 201504 acquisition of Sanofi’s site in Toulouse renamed Evotec (France) SAS 2015-04-01
Univ Bayreuth–Bruker Corp: NMR magnet, 201504 supply installation of Ascend Aeon 900 MHz magnet at Research Center for Bio-Macromolecules 2015-04-01
Bayer–MIT: personalised cardiovascular drugs, 201503– collab €na cardiovascular genomics + drug discovery with Broad Institute 2015-03-31
Sonormed–Hamburg (govt): investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–High-Tech Gründerfonds: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
Sonormed–SEVERAL: investment, 201503 financing round Series A co-led by HTGF + Innovationsstarter Fonds Hamburg 2015-03-31
vivoPharm–Protea Biosciences: investment, 201503–201601 acquisition $12m in cash + shares subject to raising necessary financing NOT REALISED 2015-03-31
AbbVie–BioMed X: pharma research, 201503– collab €na new BioMed X research group to discover Alzheimer’s treatment 2015-03-30
Aduro Biotech–Novartis: investment, 201503 initial equity investment of $25m as part of alliance w addit $25m commited at future date 2015-03-30
Merck (DE)–Intrexon: cancer immunotherapy, 201503– collab + license excl $115m upfront + $826m milestones + royalties CAR-T cancer therapies 2015-03-30
Novartis–Aduro Biotech: cancer immunotherapy, 201503– strategic alliance $200m upfront + $25m investment + profit sharing + royalties STING agonists 2015-03-30
Analytik Jena–SEVERAL: investment, 201503 DELISTING from regulated market of Frankfurt Stock Exchange 2015-03-26
Apceth–MacDougall Biomedical Communications: public relations, 201503 service existent by MacDougall Munich Office 2015-03-26
Asahi Kasei–Evotec: drug discovery, 201503– supply service €na screening for inhibitors of ion channel targets 2015-03-26
Biocartis–Microbiome: molecular diagnostics, 201503– collab developm intergrated multiplex RT-PCR sepsis test on Idylla platform 2015-03-26
Sumitomo–Evolva: agri bioactives, 201503– collab excl developm + commercialisation of ingredient class by Valent BioSciences 2015-03-26
Mologen–SEVERAL: investment, 201503–201504 capital increase €28.3m with 5.66m new shares at €5/share 2015-03-24
Rigontec–Forbion: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–SEVERAL: investment, 201503 financing round Series A 2nd closing €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Rigontec–Sunstone Capital: investment, 201503 financing round Series A 2nd closing totalling €4.8m from Forbion Capital + Sunstone Capital 2015-03-24
Genetrix (ES)–CR Comunicacion: public relations, 201503 service existent for Sygnis by CR Comunicacion 2015-03-23
HalioDx–SEVERAL: investment, 201503 financing round Series A €7.5m for founding as MBO from Qiagen Marseille 2015-03-23
Joint Polish Investment Fund–SEVERAL: investment, 201503 first $42m closing of JPIF I supported by NCBR 2015-03-23
Sanofi–Evotec: drug discovery, 201503– collab strategic alliance 5 years minimum €250m with €40m upfront 2015-03-20
GATC Biotech–Qiagen: genomic s/w, 201503– license to Ingenuity Variant Analysis s/w + integration w InView Human Exome 2015-03-19
Sigma-Aldrich–Roche: biochemical reagents, 201503– distribution ww excl of Roche biochemical reagents portfolio 2015-03-19
Sopachem–Genetrix (ES): nucleic acid amplification technology, 201503– distribution of Sygnis TruePrime products in Belgium 2015-03-19
Bayer–Genedata: bioinformatics, 201503– supply + collab developm cell line development (CLD) data platform Bayer Pharma 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–201703 US bond $250m 2y floating rate w 0.35% spread over 3-month USD LIBOR EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–201803 US bond $400m 3y coupon of 1.7% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202003 US bond $750m 5y coupon of 2.4% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202203 US bond $1b 7y 2.95% EMD Finance LLC 2015-03-17
Merck (DE)–SEVERAL: credit, 201503–202503 US bond $1.6b 10y 3.25% EMD Finance LLC 2015-03-17
NEO New Oncology–SEVERAL: investment, 201503 financing round €na to prepare market launch of NEOliquid blood test 2015-03-17
AdnaGen–Qiagen: investment, 201503 acquisition of assets by Qiagen via newly established Qiagen Hannover GmbH 2015-03-16
Boehringer–Artes Biotechnology: vaccine technology, 201503– collab using Hansenula expression system + Metavax platform for animal vaccine development 2015-03-16
Selvita–Bruker Corp: mass spectrometer, 201503 supply existent use of microflex LT MALDI-TOF MS system by Selvita 2015-03-16
Selvita–Thermo Fisher: mass spectrometer, 201503 supply existent use of LC/MS/TSQ system by Selvita 2015-03-16
Tokai Pharmaceuticals–Qiagen: molecular companion diagnostics, 201503– collab developm + commercialistion of CTC-based CDx for galeterone 2015-03-16
United States (govt)–Lumora: nucleic acid purification, 201503– supply of Heat Elution technology to a number of US Govt Departments 2015-03-16
Monarch Catalyst–Evonik: investment, 201503– acquisition 100% €na ANNOUNCED 2015-03-11
EMBL–Ingeniatrics: Cellena bio-encapsulation device, 201503 supply acquisition of device by EMBL 2015-03-10
Merck (DE)–Agilent: companion diagnostics, 201503 collab existent of Merck Serono + Dako 2015-03-10
Merck (DE)–Illumina: molecular diagnostics, 201503– collab strategic alliance ww for sequencing-based cancer tests Merck Serono 2015-03-10
Ozyme–Genetrix (ES): nucleic acid amplification technology, 201503– distribution non-excl of Sygnis TruePrime products in France by Ozyme 2015-03-10
Addex–SEVERAL: investment, 201503 private placement CHF2.8m with 1.53m new shares led by Herculis Partners SA 2015-03-09
Bayer–ACD/Labs: cheminformatics tools, 201503 supply existent customer Bayer CropScience 2015-03-09
Roche–ACD/Labs: cheminformatics tools, 201503 supply existent customer Hoffmann-LaRoche 2015-03-09
Wageningen Univ–Thermo Fisher: mass spectrometer, 201503 supply existent Hans Mol RIKILT Wageningen UR early access user of Q Exactive Focus 2015-03-09
Arrowhead–Novartis: RNAi technology, 201503 acquisition $10m cash + $25m shares + milestones + royalties of entire RNAi RnD portfolio 2015-03-05
CureVac–Gates Foundation: investment, 201503 equity investment €46m by Gates Foundation 2015-03-05
CureVac–Hopp Group: investment, 201503 equity investment €21m by dievini Hopp BioTech Holding 2015-03-05
CureVac–SEVERAL: investment, 201503 private placement €67m from Gates Foundation + dievini Hopp BioTech 2015-03-05
Analyticon Biotechnologies–908 Devices: mass spetrometer, 201503– distribution of M908 MS system by Analyticon in DACH region 2015-03-04
SuppreMol–Baxter: investment, 201503 acquisition for €200m before working capital + other adjustments by Baxter BioScience Business 2015-03-04
Aerodyne–Tofwerk: mass spectrometer, 201503 supply existent OEM of ToF MS systems for Aerodyne products 2015-03-03
Ionicon–Tofwerk: mass spectrometer, 201503 supply existent OEM of ToF MS systems for Ionicon products 2015-03-03
Pfizer–Genedata: bioinformatics, 201503– supply license to Genedata Biologics enterprise platform for Pfizer RnD Sites in US + Europe 2015-03-03
Danaher–Berlin (govt): MS compound library, 201503– collab developm hybrid Q-TOF MS/MS reference library for forensics by Sciex + Labor Berlin 2015-03-02
Imevax–Germany (govt): investment, 201503 KfW invests in 2nd closing of Series A financing 2015-03-02
Albiogen–Illumina: DNA sequencing technology, 201503– distribution of Illumina platforms + solutions in RU + Belarus + Kazakhstan by Albiogen 2015-03-01
APR Applied Pharma Research–HBM: investment, 201503 acquisition of €na minority stake by HBM Partners 2015-03-01
Bayer–Flagship Ventures: agri life sciences, 201503– strategic innovation partnership €na incl investment Bayer CropScience in Flagship Ventures Fund 2015-03-01
Flagship Ventures–AstraZeneca: investment, 201503 strategic investment by AstraZeneca in $537m Flagship Ventures Fund V 2015-03-01
Flagship Ventures–Bayer: investment, 201503 strategic investment €na by Bayer CropScience in $537m Flagship Ventures Fund V 2015-03-01
Flagship Ventures–Nestlé: investment, 201503 strategic investment by Nestlé Health Science in $537m Flagship Ventures Fund V 2015-03-01
Funakoshi–Genetrix (ES): nucleic acid amplification technology, 201503– distribution non-excl of Sygnis’ TruePrime products in Japan by Funakoshi 2015-03-01
Genenta Science–SEVERAL: investment, 201503 financing round Series A €10m 2015-03-01
NUA GmbH–Eurofins: investment, 201503 acquisition by Eurofins 2015-03-01
RiNA GmbH–Biotechrabbit: investment, 201503 acquisition of assets + lab + staff of bankrupt RiNA GmbH by Biotechrabbit GmbH 2015-03-01
Finistere–AVAC: investment, 201502 1st closing totalling $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Finistere–Bayer: investment, 201502 1st closing totalling $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Finistere–SEVERAL: investment, 201502 1st closing $150m Finistere II Agtech Fund in collab w Bayer CropScience + AVAC Ltd 2015-02-25
Canbex Therapeutics–Ipsen: investment, 201502 Ipsen pays €6m upfront for option to acquire Canbex upon Ph2a completion of VSN16R in MS spasticity 2015-02-24
Prexton Therapeutics–Merck (DE): investment, 201502 financing round Series A totalling €8.7m incl returning founding + co-investor MS Ventures 2015-02-24
Prexton Therapeutics–SEVERAL: investment, 201502 financing round Series A €8.7m co-led by Sunstone Capital + Ysios Capital plus MS Ventures 2015-02-24
Prexton Therapeutics–Sunstone Capital: investment, 201502 financing round Series A totalling €8.7m incl co-lead investor Sunstone Capital 2015-02-24
Prexton Therapeutics–Ysios Capital: investment, 201502 financing round Series A totalling €8.7m incl co-lead investor Ysios Capital 2015-02-24
Roche–BioMed X: bio sensors, 201502– collab new BioMed X research group to discover nanomaterial-based bio sensors for near-patient testing 2015-02-24
Heptares–Sosei: investment, 201502 acquisition 100% for $180m in cash + $220m milestones to continue as UK subsidiary 2015-02-23
NBE Therapeutics–Boehringer: investment, 201502 financing round Series A totalling CHF3m led by Boehringer Ingelheim Venture Fund 2015-02-20
NBE Therapeutics–SEVERAL: investment, 201502 financing round Series A CHF3m led by Boehringer Ingelheim Venture Fund 2015-02-20
Argen-X–Lonza: gene expression system, 201502– license multi-product for GS Xceed System for production of therapeutic antibodies 2015-02-18
Boehringer–Genedata: bioinformatics, 201502– supply license to Genedata Biologics platform for BI RnD Sites in US + Europe 2015-02-18
D-Mark Biosciences–Genetrix (ES): nucleic acid amplification technology, 201502– distribution of Sygnis TruePrime Single Cell WGA kit in Canada 2015-02-18
Immunservice–High-Tech Gründerfonds: investment, 201502 financing round Series C incl existing investor HTGF 2015-02-18
Immunservice–SEVERAL: investment, 201502 financing round Series C from Michael Otto + Helmut Ponath + Hubertus-Wald-Stiftung + HTGF + Hartwig Huland 2015-02-18
Immune Targeting Systems–Vaxin: investment, 201502 acquisition merger in shares 2015-02-17
AC Immune–Michael J Fox Foundation: grant, 201502 research grant €na for developm of PET tracers for alpha-synuclein protein in Parkinson diagnosis 2015-02-12
Evotec–ChemAxon: cheminformatics, 201502– supply use of ChemAxon’s Compliance Checker to aid controlled substance management 2015-02-12
Merck (US)–XL-protein: PASylation technology, 201502– license excl ww + co-developm several biopharmaceuticals for MSD Animal Health 2015-02-12
TiGenix–Lonza: cell therapy contract manufacturing, 201502– supply of Cx601 for US phase 3 study + potentially marketing 2015-02-12
Galapagos–Flanders (govt): grant, 201502 IWT grant €1.6m to develop antiviral for hepatitis B w Univ Leuven + Univ Hospital Heidelberg 2015-02-11
GlycoVaxyn–GSK: investment, 201502 acquisition of all remaining shares for $190m by GSK 2015-02-11
Boehringer–VTU: recombinant protein production, 201502– collab ww renewal of agreem for Pichia pastoris technology 2015-02-10
JnJ–Valneva: investment, 201502 acquisition €45m of Crucell Sweden AB + affiliates incl all assets related to Dukoral 2015-02-10
next pagenext page 1 2 3 ... 22 23 24 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top